Epstein Secrets

e AP (10/22, Marchione) reports that the "antiviral medicine given to hospitalized patients through an IV," being marketed by manufacturer Gilead as Veklury, "cut the time to recovery by five days - from 15 days to 10 on average - in a large study led by the U.S. National Institutes of Health." The drug

e incident. Radical Cleric Seeks To Reimpose Islamic Law In Afghanistan. The New York Times (10/22, Zucchino, Rahim, Huylebroek, 18.61M) reports in Herat, Afghanistan, "religious vigilantes loyal to a local cleric patrol the streets, routinely detaining and interrogating couples they suspect are unma

63> (10/22, Marchione) reports that the "antiviral medicine given to hospitalized patients through an IV," being marketed by manufacturer Gilead as Veklury, "cut the time to recovery by five days - from 15 days to 10 on average — in a large study led by the U.S. National Institutes of Health." The drug

York Times <https://vvwvv.nytimes.com/2020/10/22/world/asia/afghanistan-cleric-shariah.html> (10122, Zucchino, Rahim, Huylebroek, 18.61M) reports in Herat, Afghanistan, "religious vigilantes loyal to a local cleric patrol the streets, routinely detaining and interrogating couples they suspect are unmar

e AP (10/22, Marchione) reports that the "antiviral medicine given to hospitalized patients through an IV," being marketed by manufacturer Gilead as Veklury, "cut the time to recovery by five days - from 15 days to 10 on average - in a large study led by the U.S. National Institutes of Health." The drug

e incident. Radical Cleric Seeks To Reimpose Islamic Law In Afghanistan. The New York Times (10/22, Zucchino, Rahim, Huylebroek, 18.61M) reports in Herat, Afghanistan, "religious vigilantes loyal to a local cleric patrol the streets, routinely detaining and interrogating couples they suspect are unma